Mexican company of the pharmaceutical business of Johnson & Johnson, which traded as Janssen-Cilag until the group renamed the business Johnson & Johnson Innovative Medicine in 2023. Sells prescription medicines in Mexico in oncology, immunology, neuroscience, infectious diseases and pulmonary hypertension, runs clinical trials with Mexican hospitals and handles regulatory affairs, pharmacovigilance and medical information for the Mexican market.
Chưa có bình luận nào.
Để lại đánh giá & nhận xét